Advanced liver fibrosis secondary to methotrexate treatment [4];Fibrosis hepática avanzada secundaria a tratamiento con metotrexato

Gastroenterologia y Hepatologia

Volumn 26, Issue 9, 2003, Pages 617-618

  Polo Romero, F J ^a   Blasco Colmenarejo, M M ^a   Tirado Miranda, R ^a   Navarro Martinez A ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALBACETE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE;

ADULT; ASTHMA; BLOOD TOXICITY; CASE REPORT; DISEASE SEVERITY; DYSPEPSIA; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HYPOALBUMINEMIA; LETTER; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER TOXICITY; LUNG TOXICITY; NAUSEA; RISK FACTOR; STOMATITIS;

EID: 0346881699     PISSN: 02105705     EISSN: None     Source Type: Journal    
DOI: 10.1157/13054456     Document Type: Letter

References (10)

1. King PD, Perry MC. Hepatotoxicity of chemotherapeutic and oncologic agents. Gastroenterol Clin North Am 1995;24:969-90.
2. Goodman TA, Polisson RP. Methotrexate: adverse reactions and major toxicities. Rheum Dis Clin North Am 1994;20:513-29.
3. Schnabel A, Gross WL. Low-dose methotrexate in rheumatic disease-efficacy, side effects, and risk factors for side effects. Sem Arthritis Rheum 1994;23:310-27.
4. McKendry RJR, Dale P. Adverse effects of low dose methotrexate therapy in rheumatoid arthritis. J Rheumatol 1993;20: 1850-6.
5. Walker AM, Funch D, Dreyer NA, Tolman KG, Kremer JM, Alarcón GS, et al. Determinants of serious liver disease among patients receiving low-dose methotrexate for rheumatoid arthritis. Arthritis Rheum 1993;36:329-35.
6. Phillips CA, Cera PJ, Mangan TF, Newman ED. Clinical liver disease in patients with rheumatoid arthritis taking methotrexate. J Rheumatol 1992;19:229-33.
7. Kremer JM, Lee RG, Tolman KG. Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy. Arthritis Rheum 1989;32:121-7.
8. Erickson AR, Reddy V, Vogelgesang SA, West SG. Usefulness of american college of rheumatology recommendations for liver biopsy in methotrexate-treated rheumatoid arthritis patients. Arthritis Rheum 1995;38:115-9.
9. Kremer JM. Liver biopsies in patients with rheumatoid arthritis receiving methotrexate: where are we going? J Rheumatol 1992; 19:189-91.
10. Kremer JM, Alarcón GS, Lightfoot RW Jr, Willkens RF, Furst DE, Williams HJ, et al. Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology. Arthritis Rheum 1994;37:316-28.